The DOI matches its Crossref record; 136 of the 136 references it cites were found in a registry or an index.
Early Diagnosis of Complex Diseases by Molecular Biomarkers, Network Biomarkers, and Dynamical Network Biomarkers
Abstract
Many studies have been carried out for early diagnosis of complex diseases by finding accurate and robust biomarkers specific to respective diseases. In particular, recent rapid advance of high‐throughput technologies provides unprecedented rich information to characterize various disease genotypes and phenotypes in a global and also dynamical manner, which significantly accelerates the study of biomarkers from both theoretical and clinical perspectives. Traditionally, molecular biomarkers that distinguish disease samples from normal samples are widely adopted in clinical practices due to their ease of data measurement. However, many of them suffer from low coverage and high false‐positive rates or high false‐negative rates, which seriously limit their further clinical applications. To overcome those difficulties, network biomarkers (or module biomarkers) attract much attention and also achieve better performance because a network (or subnetwork) is considered to be a more robust form to characterize diseases than individual molecules. But, both molecular biomarkers and network biomarkers mainly distinguish disease samples from normal samples, and they generally cannot ensure to identify predisease samples due to their static nature, thereby lacking ability to early diagnosis. Based on nonlinear dynamical theory and complex network theory, a new concept of dynamical network biomarkers (DNBs, or a dynamical network of biomarkers) has been developed, which is different from traditional static approaches, and the DNB is able to distinguish a predisease state from normal and disease states by even a small number of samples, and therefore has great potential to achieve “real” early diagnosis of complex diseases. In this paper, we comprehensively review the recent advances and developments on molecular biomarkers, network biomarkers, and DNBs in particular, focusing on the biomarkers for early diagnosis of complex diseases considering a small number of samples and high‐throughput data (or big data). Detailed comparisons of various types of biomarkers as well as their applications are also discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cytoscape: A software Environment for integrated models of biomolecular interaction networks
Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., & Ideker, T. (2003) · Genome Research · doi:10.1101/gr.1239303 · Cited by 51,888
Emergence of Scaling in Random Networks
Barabási, A.-L., & Albert, R. (1999) · Science · doi:10.1126/science.286.5439.509 · Cited by 36,135
(1990) · Choice Reviews Online · doi:10.5860/choice.27-3338 · Cited by 35,305
Wu, Y. (1999) · Technometrics · doi:10.1080/00401706.1999.10485951 · Cited by 27,221
A Tutorial on Support Vector Machines for Pattern Recognition
Burges, C. J. C. (1998) · Data Mining and Knowledge Discovery · doi:10.1023/a:1009715923555 · Cited by 16,429
Golub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., et al. (1999) · Science · doi:10.1126/science.286.5439.531 · Cited by 11,516
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
Kupper, L. L., Hosmer, D. W., & Lemeshow, S. (1990) · Journal of the American Statistical Association · doi:10.2307/2290035 · Cited by 7,599
Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework
(2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.113989 · Cited by 6,762
Network medicine: a network-based approach to human disease
Barabási, A.-L., Gulbahce, N., & Loscalzo, J. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2918 · Cited by 5,034
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
Cristofanilli, M., Budd, G. T., Ellis, M. J., Stopeck, A., Matera, J., Miller, M. C., Reuben, J. M., Doyle, G. V., Allard, W. J., Terstappen, L. W. M. M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040766 · Cited by 4,593
Systems biology: a brief overview
Kitano, H. (2002) · Science · doi:10.1126/science.1069492 · Cited by 4,265
Use of proteomic patterns in serum to identify ovarian cancer
Petricoin, E. F., Ardekani, A. M., Hitt, B. A., Levine, P. J., Fusaro, V. A., Steinberg, S. M., Mills, G. B., Simone, C., Fishman, D. A., Kohn, E. C., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07746-2 · Cited by 3,236
Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy
Rouzier, R., Perou, C. M., Symmans, W. F., Ibrahim, N., Cristofanilli, M., Anderson, K., Hess, K. R., Stec, J., Ayers, M., Wagner, P., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2421 · Cited by 1,891
Gene-Expression Profiles in Hereditary Breast Cancer
Hedenfalk, I., Duggan, D., Chen, Y., Radmacher, M., Bittner, M., Simon, R., Meltzer, P., Gusterson, B., Esteller, M., Raffeld, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102223440801 · Cited by 1,733
Estimating Optimal Transformations for Multiple Regression and Correlation
Breiman, L., & Friedman, J. H. (1985) · Journal of the American Statistical Association · doi:10.1080/01621459.1985.10478157 · Cited by 1,710
Phases of Biomarker Development for Early Detection of Cancer
Pepe, M. S., Etzioni, R., Feng, Z., Potter, J. D., Thompson, M. L., Thornquist, M., Winget, M., & Yasui, Y. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.14.1054 · Cited by 1,686
Genotype imputation for genome-wide association studies
Marchini, J., & Howie, B. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2796 · Cited by 1,627
Network‐based classification of breast cancer metastasis
Chuang, H., Lee, E., Liu, Y., Lee, D., & Ideker, T. (2007) · Molecular Systems Biology · doi:10.1038/msb4100180 · Cited by 1,431
Lessons from the Cancer Genome
Garraway, L. A., & Lander, E. S. (2013) · Cell · doi:10.1016/j.cell.2013.03.002 · Cited by 1,308
Scale-free networks in cell biology
Albert, R. (2005) · Journal of Cell Science · doi:10.1242/jcs.02714 · Cited by 1,215
Discovering regulatory and signalling circuits in molecular interaction networks
Ideker, T., Ozier, O., Schwikowski, B., & Siegel, A. F. (2002) · Bioinformatics · doi:10.1093/bioinformatics/18.suppl_1.s233 · Cited by 1,197
Zhang, G., & Tandon, A. (2012) · Scientific Reports · doi:10.1038/srep00415 · Cited by 1,012
Li, Y., Willer, C., Sanna, S., & Abecasis, G. (2009) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.9.081307.164242 · Cited by 990
Pathway-Based Approaches for Analysis of Genomewide Association Studies
Wang, K., Li, M., & Bucan, M. (2007) · The American Journal of Human Genetics · doi:10.1086/522374 · Cited by 858
Ideker, T., & Sharan, R. (2008) · Genome Research · doi:10.1101/gr.071852.107 · Cited by 817
Molecular networks as sensors and drivers of common human diseases
Schadt, E. E. (2009) · Nature · doi:10.1038/nature08454 · Cited by 806
Analysing biological pathways in genome-wide association studies
Wang, K., Li, M., & Hakonarson, H. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2884 · Cited by 766
Pepe, M. S., Feng, Z., Janes, H., Bossuyt, P. M., & Potter, J. D. (2008) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djn326 · Cited by 717
Dynamic modularity in protein interaction networks predicts breast cancer outcome
Taylor, I. W., Linding, R., Warde-Farley, D., Liu, Y., Pesquita, C., Faria, D., Bull, S., Pawson, T., Morris, Q., & Wrana, J. L. (2009) · Nature Biotechnology · doi:10.1038/nbt.1522 · Cited by 697
Molecular classification of human carcinomas by use of gene expression signatures.
Su, A. I., Welsh, J. B., Sapinoso, L. M., Kern, S. G., Dimitrov, P., Lapp, H., Schultz, P. G., Powell, S. M., Moskaluk, C. A., Frierson, H. F., et al. (2001) · PubMed · Cited by 688
Chen, L., Liu, R., Liu, Z.-P., Li, M., & Aihara, K. (2012) · Scientific Reports · doi:10.1038/srep00342 · Cited by 654
Self-citationSalivary Transcriptome Diagnostics for Oral Cancer Detection
Li, Y., St. John, M. A. R., Zhou, X., Kim, Y., Sinha, U., Jordan, R. C. K., Eisele, D., Abemayor, E., Elashoff, D., Park, N.-H., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1167 · Cited by 625
Adam, B.-L., Qu, Y., Davis, J. W., Ward, M. D., Clements, M. A., Cazares, L. H., Semmes, O. J., Schellhammer, P. F., Yasui, Y., Feng, Z., et al. (2002) · PubMed · Cited by 612
Inferring Pathway Activity toward Precise Disease Classification
Lee, E., Chuang, H.-Y., Kim, J.-W., Ideker, T., & Lee, D. (2008) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000217 · Cited by 600
Self-organized patchiness in asthma as a prelude to catastrophic shifts
Venegas, J. G., Winkler, T., Musch, G., Vidal Melo, M. F., Layfield, D., Tgavalekos, N., Fischman, A. J., Callahan, R. J., Bellani, G., & Scott Harris, R. (2005) · Nature · doi:10.1038/nature03490 · Cited by 572
Prostate‐specific antigen: A review of the validation of the most commonly used cancer biomarker
Hernández, J., & Thompson, I. M. (2004) · Cancer · doi:10.1002/cncr.20480 · Cited by 527
Algorithms for Detecting Significantly Mutated Pathways in Cancer
Vandin, F., Upfal, E., & Raphael, B. J. (2011) · Journal of Computational Biology · doi:10.1089/cmb.2010.0265 · Cited by 430
Future Biomarkers for Detection of Ischemia and Risk Stratification in Acute Coronary Syndrome
Apple, F. S. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2004.046292 · Cited by 426
Proteomics of early zebrafish embryos
Link, V., Shevchenko, A., & Heisenberg, C.-P. (2006) · BMC Developmental Biology · doi:10.1186/1471-213x-6-1 · Cited by 372
Shaping Genetic Alterations in Human Cancer: The p53 Mutation Paradigm
Soussi, T., & Wiman, K. G. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.10.001 · Cited by 368
Cancer systems biology: a network modeling perspective
Kreeger, P. K., & Lauffenburger, D. A. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp261 · Cited by 368
Lee, Y., & Lee, C.-K. (2003) · Bioinformatics · doi:10.1093/bioinformatics/btg102 · Cited by 367
Aryee, M. J., Liu, W., Engelmann, J. C., Nuhn, P., Gurel, M., Haffner, M. C., Esopi, D., Irizarry, R. A., Getzenberg, R. H., Nelson, W. G., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005211 · Cited by 275
Rhodes, D. R., Sanda, M. G., Otte, A. P., Chinnaiyan, A. M., & Rubin, M. A. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.9.661 · Cited by 271
Efficient Algorithms for Detecting Signaling Pathways in Protein Interaction Networks
Scott, J., Ideker, T., Karp, R. M., & Sharan, R. (2006) · Journal of Computational Biology · doi:10.1089/cmb.2006.13.133 · Cited by 269
Ball, G., Mian, S., Holding, F., Allibone, R. O., Lowe, J., Ali, S., Li, G., McCardle, S., Ellis, I. O., Creaser, C., et al. (2002) · Bioinformatics · doi:10.1093/bioinformatics/18.3.395 · Cited by 260
Li, X., Xu, Z., Lu, X., Yang, X., Yin, P., Kong, H., Yu, Y., & Xu, G. (2009) · Analytica Chimica Acta · doi:10.1016/j.aca.2008.11.058 · Cited by 249
Burczynski, M. E., Peterson, R. L., Twine, N. C., Zuberek, K. A., Brodeur, B. J., Casciotti, L., Maganti, V., Reddy, P. S., Strahs, A., Immermann, F., et al. (2006) · The Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2006.050079 · Cited by 249
Assessing the Value of Risk Predictions by Using Risk Stratification Tables
Janes, H., Pepe, M. S., & Gu, W. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-10-200811180-00009 · Cited by 249
Prediction of epileptic seizures: are nonlinear methods relevant?
McSharry, P. E., Smith, L. A., & Tarassenko, L. (2003) · Nature Medicine · doi:10.1038/nm0303-241 · Cited by 242
Landgren, O., & Weiss, B. M. (2009) · Leukemia · doi:10.1038/leu.2009.134 · Cited by 231
DNA-microarray analysis of brain cancer: molecular classification for therapy
Mischel, P. S., Cloughesy, T. F., & Nelson, S. F. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1518 · Cited by 219
Validation of Biomarker-Based Risk Prediction Models
Taylor, J. M. G., Ankerst, D. P., & Andridge, R. R. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4534 · Cited by 207
Identifying critical transitions and their leading biomolecular networks in complex diseases
Liu, R., Li, M., Liu, Z.-P., Wu, J., Chen, L., & Aihara, K. (2012) · Scientific Reports · doi:10.1038/srep00813 · Cited by 204
Self-citationTesting association between disease and multiple SNPs in a candidate gene
Gauderman, W. J., Murcray, C., Gilliland, F., & Conti, D. V. (2007) · Genetic Epidemiology · doi:10.1002/gepi.20219 · Cited by 202
Biomarker discovery and validation: technologies and integrative approaches
Ilyin, S. E., Belkowski, S. M., & Plata-Salamán, C. R. (2004) · Trends in Biotechnology · doi:10.1016/j.tibtech.2004.06.005 · Cited by 195
Multiclass cancer classification and biomarker discovery using GA-based algorithms
Liu, J. J., Cutler, G., Li, W., Pan, Z., Peng, S., Hoey, T., Chen, L., & Ling, X. B. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bti419 · Cited by 185
Self-citationHearing preservation after gamma knife stereotactic radiosurgery of vestibular schwannoma
Paek, S. H., Chung, H., Jeong, S. S., Park, C., Kim, C., Kim, J. E., Kim, D. G., & Jung, H. (2005) · Cancer · doi:10.1002/cncr.21190 · Cited by 182
Diagnosis of Ovarian Cancer Using Decision Tree Classificationof Mass Spectral Data
Vlahou, A., Schorge, J. O., Gregory, B. W., & Coleman, R. L. (2003) · BioMed Research International · doi:10.1155/s1110724303210032 · Cited by 182
Gene Discovery in Bladder Cancer Progression using cDNA Microarrays
Sanchez-Carbayo, M., Socci, N. D., Lozano, J. J., Li, W., Charytonowicz, E., Belbin, T. J., Prystowsky, M. B., Ortiz, A. R., Childs, G., & Cordon-Cardo, C. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63679-6 · Cited by 181
Network-Based Analysis of Affected Biological Processes in Type 2 Diabetes Models
Liu, M., Liberzon, A., Kong, S. W., Lai, W. R., Park, P. J., Kohane, I. S., & Kasif, S. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030096 · Cited by 180
A Personalized Approach to Cancer Treatment: How Biomarkers Can Help
Duffy, M. J., & Crown, J. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.110056 · Cited by 173
Tumor markers. Physiology, pathobiology, technology, and clinical applications
Wu, A. H. B. (2003) · Clinica Chimica Acta · doi:10.1016/s0009-8981(03)00049-4 · Cited by 172
Krauthammer, M., Kaufmann, C. A., Gilliam, T. C., & Rzhetsky, A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404315101 · Cited by 167
Ransohoff, D. F. (2007) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2007.04.020 · Cited by 163
Proteomic approaches to biomarker discovery in prostate and bladder cancers
Adam, B.-L., Vlahou, A., Semmes, O. J., & Wright, Jr. (2001) · PROTEOMICS · doi:10.1002/1615-9861(200110)1:10<1264::aid-prot1264>3.0.co;2-r · Cited by 162
Eleftherohorinou, H., Wright, V., Hoggart, C. J., Hartikainen, A., Järvelin, M., Balding, D. J., Coin, L., & Levin, M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008068 · Cited by 157
He, Y., Zheng, X., Sit, C. H. P., Loo, W. T., Wang, Z., Xie, T., Jia, B., Ye, Q., Tsui, K., Chow, L. W. C., et al. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-s1-s12 · Cited by 157
Approaches to dimensionality reduction in proteomic biomarker studies
Hilario, M., & Kalousis, A. (2007) · Briefings in Bioinformatics · doi:10.1093/bib/bbn005 · Cited by 153
Urine Collection and Processing for Protein Biomarker Discovery and Quantification
Thomas, C. E., Sexton, W. J., Benson, K., Sutphen, R., & Koomen, J. M. (2010) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0069 · Cited by 151
Li, M., Zeng, T., Liu, R., & Chen, L. (2013) · Briefings in Bioinformatics · doi:10.1093/bib/bbt027 · Cited by 142
Self-citationMammographic patterns as a predictive biomarker of breast cancer risk: effect of tamoxifen.
Atkinson, C., Warren, R. M. L., Bingham, S. A., & Day, N. E. (1999) · PubMed · Cited by 142
Zhang, B., Li, H., Riggins, R. B., Zhan, M., Xuan, J., Zhang, Z., Hoffman, E. P., Clarke, R. C., & Wang, Y. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btn660 · Cited by 137
Development of a mathematical model that predicts the outcome of hormone therapy for prostate cancer
Hirata, Y., Bruchovsky, N., & Aihara, K. (2010) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2010.02.027 · Cited by 134
Self-citationClinical bioinformatics: a new emerging science
Wang, X., & Liotta, L. A. (2011) · Journal of Clinical Bioinformatics · doi:10.1186/2043-9113-1-1 · Cited by 133
Self-citationIdentifying disease genes and module biomarkers by differential interactions
Liu, X., Liu, Z.-P., Zhao, X., & Chen, L. (2011) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2011-000658 · Cited by 130
Self-citationTumor Markers : Physiology, Pathobiology, Technology, and Clinical Applications
Fritsche, H. A., Diamandis, E. P., & Lilja, H. G. (2002) · Cited by 126
Identifying dysregulated pathways in cancers from pathway interaction networks
Liu, K.-Q., Liu, Z.-P., Hao, J., Chen, L., & Zhao, X. (2012) · BMC Bioinformatics · doi:10.1186/1471-2105-13-126 · Cited by 126
Self-citationHuman Biospecimen Research: Experimental Protocol and Quality Control Tools
Betsou, F., Barnes, R. O., Burke, T. W., Coppola, D., DeSouza, Y., Eliason, J. F., Glazer, B., Horsfall, D. J., Kleeberger, C. A., Lehmann, S., et al. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-1231 · Cited by 114
Classification of Breast Cancer Using Genetic Algorithms and Tissue Microarrays
Dolled-Filhart, M. P., Rydén, L., Cregger, M. A., Jirström, K., Harigopal, M., Camp, R. L., & Rimm, D. L. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1383 · Cited by 108
Network-based support vector machine for classification of microarray samples
Zhu, Y., Shen, X., & Pan, W. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-s1-s21 · Cited by 107
Wei, J. T., Zhang, Z., Barnhill, S. D., Madyastha, K. R., Zhang, H., & Oesterling, J. E. (1998) · Urology · doi:10.1016/s0090-4295(98)00181-2 · Cited by 104
Liu, X., Liu, R., Zhao, X.-M., & Chen, L. (2013) · BMC Medical Genomics · doi:10.1186/1755-8794-6-s2-s8 · Cited by 103
Self-citationJimeno, A., & Hidalgo, M. M. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0005 · Cited by 103
Signaling pathway networks mined from human pituitary adenoma proteomics data
Zhan, X., & Desiderio, D. M. (2010) · BMC Medical Genomics · doi:10.1186/1755-8794-3-13 · Cited by 101
Optimally discriminative subnetwork markers predict response to chemotherapy
Dao, P., Wang, K., Collins, C. C., Ester, M., Lapuk, A. V., & Şahinalp, S. C. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr245 · Cited by 99
Chow, M. L., Moler, E. J., & Mian, S. I. (2001) · Physiological Genomics · doi:10.1152/physiolgenomics.2001.5.2.99 · Cited by 97
Combining biomarkers to detect disease with application to prostate cancer
Etzioni, R., Kooperberg, C. L., PEPE, M. S., Smith, R. V., & Gann, P. H. (2003) · Biostatistics · doi:10.1093/biostatistics/4.4.523 · Cited by 96
Xue, X., Kim, M., Gaudet, M. M., Park, Y., Heo, M., Hollenbeck, A. R., Strickler, H. D., & Gunter, M. J. (2013) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-1050 · Cited by 95
Ptolemy, A. S., & Rifai, N. (2010) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2010.493354 · Cited by 94
A network-based biomarker approach for molecular investigation and diagnosis of lung cancer
Wang, Y., & Chen, B. (2011) · BMC Medical Genomics · doi:10.1186/1755-8794-4-2 · Cited by 94
Liu, Y., Shin, S., Zeng, X., Zhan, M., Gonzalez, R., Müeller, F.-J., Schwartz, C. M., Xue, H., Li, H., Baker, S. C., et al. (2006) · BMC Developmental Biology · doi:10.1186/1471-213x-6-20 · Cited by 93
Yu, Y., Chen, S., Wang, L.-S., Chen, W.-L., Guo, W.-J., Yan, H., Zhang, W.-H., Peng, C.-H., Zhang, S.-D., Li, H.-W., et al. (2005) · Oncology · doi:10.1159/000084824 · Cited by 93
Network-based analysis of complex diseases
Liu, Z.-P., Wang, Y., Zhang, X.-S., & Chen, L. (2012) · IET Systems Biology · doi:10.1049/iet-syb.2010.0052 · Cited by 91
Self-citationAllhoff, E. P., Proppe, K. H., Chapman, C. M., et al. (1983) · The Journal of Urology · doi:10.1016/s0022-5347(17)52074-1 · Cited by 90
Identifying cancer biomarkers by network-constrained support vector machines
Chen, L., Xuan, J., Riggins, R. B., Clarke, R. C., & Wang, Y. (2011) · BMC Systems Biology · doi:10.1186/1752-0509-5-161 · Cited by 90
Self-citationLiu, R., Aihara, K., & Chen, L. (2013) · Quantitative Biology · doi:10.1007/s40484-013-0008-0 · Cited by 87
Self-citationSearching for bidirectional promoters in Arabidopsis thaliana
Wang, Q., Wan, L., Li, D., Zhu, L., Qian, M., & Deng, M. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-s1-s29 · Cited by 86
Detecting disease associated modules and prioritizing active genes based on high throughput data
Qiu, Y., Zhang, S., Zhang, X., & Chen, L. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-26 · Cited by 82
Self-citationPotter, S. R., Miller, M. C., Mangold, L. A., et al. (1999) · Urology · doi:10.1016/s0090-4295(99)00328-3 · Cited by 82
Xi, S. C., Siu, S., Fong, S. W., & Shiu, S. Y. W. (2001) · The Prostate · doi:10.1002/1097-0045(200101)46:1<39::aid-pros1006>3.0.co;2-m · Cited by 79
Are multiple markers the future of prostate cancer diagnostics?
Mikolajczyk, S. D., Song, Y. S., Wong, J. R., Matson, R. S., & Rittenhouse, H. G. (2004) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2004.05.016 · Cited by 79
Xu, M., Kao, M. J., Nunez-Iglesias, J., Nevins, J. R., West, M., & Zhou, X. J. (2008) · BMC Genomics · doi:10.1186/1471-2164-9-s1-s12 · Cited by 75
NORMALIZATION REGARDING NON-RANDOM MISSING VALUES IN HIGH-THROUGHPUT MASS SPECTROMETRY DATA
Wang, P., Tang, H., Zhang, H., Whiteaker, J. R., Paulovich, A. G., & McIntosh, M. W. (2005) · Pacific Symposium on Biocomputing (PSB) · doi:10.1142/9789812701626_0029 · Cited by 74
Nguyen, V. T., Cao, L., Lin, J. T., Hung, N., Ritz, A., Yu, K., Jianu, R., Ulin, S. P., Raphael, B. J., Laidlaw, D. H., et al. (2009) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m800307-mcp200 · Cited by 74
The Knowledge-Integrated Network Biomarkers Discovery for Major Adverse Cardiac Events
Jin, G., Zhou, X., Wang, H., Zhao, H. C., Cui, K., Zhang, X.-S., Chen, L., Hazen, S. L., Li, K. C., & Wong, S. T. C. (2008) · Journal of Proteome Research · doi:10.1021/pr8002886 · Cited by 71
Self-citationVaccine therapy for pancreatic cancer
Salman, B., Zhou, D., Jaffee, E. M., Edil, B. H., & Zheng, L. (2013) · OncoImmunology · doi:10.4161/onci.26662 · Cited by 64
Toivanen, R., Frydenberg, M., Murphy, D., Pedersen, J., Ryan, A., Pook, D. W., Berman, D. M., BioResource, A. P. C., Taylor, R. A., & Risbridger, G. P. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005688 · Cited by 63
Midline and right frontal brain function as a physiologic biomarker of remission in major depression
Cook, I. A., Hunter, A. M., Abrams, M., Siegman, B., & Leuchter, A. F. (2009) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2009.04.011 · Cited by 59
Mian, S., Ball, G., Hornbuckle, J., Holding, F. P., Carmichael, J., Ellis, I. O., Ali, S., Li, G., McArdle, S., Creaser, C. S., et al. (2003) · PROTEOMICS · doi:10.1002/pmic.200300526 · Cited by 59
Statistical methods on detecting differentially expressed genes for RNA-seq data
Chen, Z., Liu, J., Ng, H. K. T., Nadarajah, S., Kaufman, H. L., Yang, J. Y., & Deng, Y. (2011) · BMC Systems Biology · doi:10.1186/1752-0509-5-s3-s1 · Cited by 58
Robin, X., Turck, N., Hainard, A., Lisacek, F., Sanchez, J., & Müller, M. (2009) · Expert Review of Proteomics · doi:10.1586/epr.09.83 · Cited by 58
Role of clinical bioinformatics in the development of network-based Biomarkers
Wang, X. (2011) · Journal of Clinical Bioinformatics · doi:10.1186/2043-9113-1-28 · Cited by 58
Self-citationHe, D., Liu, Z., & Chen, L. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-592 · Cited by 57
Self-citationAntibody Complementarity-Determining Regions (CDRs): A Bridge between Adaptive and Innate Immunity
Gabrielli, E., Pericolini, E., Cenci, E., Federica, O., Magliani, W., Ciociola, T., Bistoni, F., Conti, S., Vecchiarelli, A., & Polonelli, L. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008187 · Cited by 53
ATOM: a powerful gene-based association test by combining optimally weighted markers
Li, M., Wang, K., Grant, S. F. A., Hakonarson, H. H., & Li, C. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btn641 · Cited by 53
Zlobec, I., Steele, R. J., Nigam, N., & Compton, C. C. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2587 · Cited by 50
Poste, G. H., Carbone, D. P., Parkinson, D. R., Verweij, J., Hewitt, S. M., & Jessup, J. M. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2206 · Cited by 49
Molecular profiling approaches for identifying novel biomarkers
Bailey, W. J., & Ulrich, R. G. (2004) · Expert Opinion on Drug Safety · doi:10.1517/14740338.3.2.137 · Cited by 49
Network screening of Goto-Kakizaki rat liver microarray data during diabetic progression
Zhou, H., Saito, S., Piao, G., Liu, Z.-P., Wang, J., Horimoto, K., & Chen, L. (2011) · BMC Systems Biology · doi:10.1186/1752-0509-5-s1-s16 · Cited by 48
Self-citationLocal Function Conservation in Sequence and Structure Space
Weinhold, N., Sander, O., Domingues, F. S., Lengauer, T., & Sommer, I. (2008) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000105 · Cited by 43
DDN: a caBIG® analytical tool for differential network analysis
Zhang, B., Tian, Y., Lu, J., Li, H., Shih, I., Madhavan, S., Clarke, R. C., Hoffman, E. P., Xuan, J., Hilakivi-Clarke, L. A., et al. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr052 · Cited by 41
Lette, J., Colletti, B. W., Cerino, M., McNamara, D., Eybalin, M., Levasseur, A., & Natnel, S. (1994) · Clinical Cardiology · doi:10.1002/clc.4960171109 · Cited by 36
Veltri, R. W., Chaudhari, M. Y., Miller, M. C., et al. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.10.1828 · Cited by 35
Systems Biology: Confronting the Complexity of Cancer
Gentles, A. J., & Gallahan, D. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1569 · Cited by 35
Bonnet, É., Michoel, T., & de Peer, Y. V. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq395 · Cited by 35
Network-Induced Classification Kernels for Gene Expression Profile Analysis
Lavi, O., Dror, G., & Ron Shamir, A. (2012) · Journal of Computational Biology · doi:10.1089/cmb.2012.0065 · Cited by 32
Xu, Q.-W., Zhao, W., Wang, Y., Sartor, M. A., Han, D.-M., Deng, J., Ponnala, R., Yang, J.-Y., Zhang, Q.-Y., Liao, G., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1656 · Cited by 32
Self-citationGARBAN: genomic analysis and rapid biological annotation of cDNA microarray and proteomic data
Martínez‐Cruz, L. A., Rubio, Á., Martínez‐Chantar, M. L., et al. (2003) · Bioinformatics · doi:10.1093/bioinformatics/btg291 · Cited by 30
Decision Tree–Based Modeling of Androgen Pathway Genes and Prostate Cancer Risk
Barnholtz‐Sloan, J. S., Guan, X., Zeigler-Johnson, C. M., Meropol, N. J., & Rebbeck, T. R. (2011) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0996 · Cited by 29
Gene Prioritization for Type 2 Diabetes in Tissue-specific Protein Interaction Networks ∗
Jiang, B., Wang, J., Xiao, J., et al. (2009) · Rare & Special e-Zone (The Hong Kong University of Science and Technology) · Cited by 20
Cross-platform method for identifying candidate network biomarkers for prostate cancer
Jin, G., Zhou, X., Cui, K., Zhang, X.-S., Chen, L., & Wong, S. T. C. (2009) · IET Systems Biology · doi:10.1049/iet-syb.2008.0168 · Cited by 16
Self-citationAn integrated genetics approach for identifying protein signal pathways of Alzheimer's disease
Huang, Y., Sun, X., & Hu, G. (2011) · Computer Methods in Biomechanics & Biomedical Engineering · doi:10.1080/10255842.2010.482525 · Cited by 10
Dynamically dysfunctional protein interactions in the development of Alzheimer's disease
Liu, Z.-P., Wang, Y., Wen, T., Zhang, X.-S., Xia, W., & Chen, L. (2009) · Conference proceedings/Conference proceedings - IEEE International Conference on Systems, Man, and Cybernetics · doi:10.1109/icsmc.2009.5346814 · Cited by 10
Self-citationHEPA and PARSE: Systematic discovery of clinically relevant tumor-specific antigens
Xu, Q.-W., Zhang, Y. X., & Wang, X.-S. (2013) · OncoImmunology · doi:10.4161/onci.23249 · Cited by 2
Self-citation
Cited by
Network pharmacology: curing causal mechanisms instead of treating symptoms
Nogales, C., Mamdouh, Z. M., List, M., Kiel, C., Casas, A. I., & Schmidt, H. H. H. W. (2022) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2021.11.004 · Cited by 1,201
Identifying critical state of complex diseases by single-sample Kullback–Leibler divergence
Zhong, J., Liu, R., & Chen, P. (2020) · BMC Genomics · doi:10.1186/s12864-020-6490-7 · Cited by 472
Self-citationPersonalized characterization of diseases using sample-specific networks
Liu, X., Wang, Y., Ji, H., Aihara, K., & Chen, L. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw772 · Cited by 317
Self-citationNetwork control principles for identifying personalized driver genes in cancer
Guo, W.-F., Zhang, S.-W., Zeng, T., Akutsu, T., & Chen, L. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbz089 · Cited by 44
Self-citation
Metadata
- Authors
- Liu, R., Wang, X., Aihara, K., & Chen, L.
- Venue
- Medicinal Research Reviews
- Publisher
- Wiley
- Published
- 2013-06-17
- Volume
- 34
- Issue
- 3
- Pages
- 455-478
- ISSN
- 0198-6325 (ISSN-L)
- 1098-1128
- OpenAlex
- W1892363833
- Cited by
- 333
- References
- 136
- FWCI
- 9.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.